UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 300

Sortiert nach

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

Nature medicine, 2013-04, Vol.19 (4), p.446-451

2013

Link zum Volltext

Verfügbarkeit prüfen

Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy

Journal of the American College of Cardiology, 2019-07, Vol.74 (3), p.285-295

2019

Link zum Volltext

Verfügbarkeit prüfen

The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancer

The Journal of pharmacology and experimental therapeutics, 2014-12, Vol.351 (3), p.538

2014

Link zum Volltext

Verfügbarkeit prüfen

SYK inhibition and response prediction in diffuse large B-cell lymphoma

Blood, 2011-12, Vol.118 (24), p.6342-6352

2011

Link zum Volltext

Verfügbarkeit prüfen

Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis

The Journal of pharmacology and experimental therapeutics, 2012-02, Vol.340 (2), p.350

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)

Thrombosis and haemostasis, 2009-01, Vol.101 (1), p.68

2009

Link zum Volltext

Verfügbarkeit prüfen

First‐in‐Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers

Clinical pharmacology in drug development, 2020-01, Vol.9 (1), p.115-129

2020

Link zum Volltext

Verfügbarkeit prüfen

Critical role for Syk in responses to vascular injury

Blood, 2011-11, Vol.118 (18), p.5000-5010

2011

Link zum Volltext

Verfügbarkeit prüfen

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-( N, N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2179-2185

2009

Link zum Volltext

Verfügbarkeit prüfen

Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles

Blood, 2011-08, Vol.118 (6), p.1549-1559

2011

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory effect of carboxylic acid group on hERG binding

Bioorganic & medicinal chemistry letters, 2006-11, Vol.16 (21), p.5507-5512

2006

Link zum Volltext

Verfügbarkeit prüfen

The HTLV-I p30 Interferes with TLR4 Signaling and Modulates the Release of Pro- and Anti-inflammatory Cytokines from Human Macrophages

The Journal of biological chemistry, 2006-08, Vol.281 (33), p.23414-23424

2006

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Induction of Tissue Factor by Coagulation Factor Xa and TNF: Evidence for Involvement of Negative Regulatory Signaling Cascades

Proceedings of the National Academy of Sciences - PNAS, 2005-08, Vol.102 (34), p.12077-12082

2005

Link zum Volltext

Verfügbarkeit prüfen

Human T-cell Lymphotrophic Virus Type I Rex and p30 Interactions Govern the Switch between Virus Latency and Replication

The Journal of biological chemistry, 2007-05, Vol.282 (19), p.14608-14615

2007

Link zum Volltext

Verfügbarkeit prüfen

GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half‐life in a murine model of sickle cell disease

British journal of haematology, 2016-10, Vol.175 (1), p.141-153

2016

Link zum Volltext

Verfügbarkeit prüfen

Benefits of leptin therapy in HIV patients

Indian journal of endocrinology and metabolism, 2012-12, Vol.16 (Suppl 3), p.S637-S643

2012

Link zum Volltext

Verfügbarkeit prüfen

Genotoxicity of crotonaldehyde in the bone marrow and germ cells of laboratory mice

Mutation research, 2007-08, Vol.632 (1), p.69-77

2007

Link zum Volltext

Verfügbarkeit prüfen

Human T-cell Leukemia Virus Type I p30 Nuclear/Nucleolar Retention Is Mediated through Interactions with RNA and a Constituent of the 60 S Ribosomal Subunit

The Journal of biological chemistry, 2006-12, Vol.281 (48), p.37150-37158

2006

Link zum Volltext

Verfügbarkeit prüfen

MO040: Development of BBP-711, a small molecule inhibitor of glycolate oxidase for primary hyperoxaluria type 1 and recurrent kidney stone formers

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)

2022

Link zum Volltext

Verfügbarkeit prüfen

Validation of a novel western blot assay to monitor patterns and levels of alpha dystroglycan in skeletal muscle of patients with limb girdle muscular dystrophies

Journal of muscle research and cell motility, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Antidote for Reversal of Anticoagulation by Factor Xa Inhibitors

Blood, 2008-11, Vol.112 (11), p.983-983

2008

Link zum Volltext

Verfügbarkeit prüfen

Acromegaly without acral changes: A rare presentation

Indian journal of endocrinology and metabolism, 2012-05, Vol.16 (3), p.457-459

2012

Link zum Volltext

Verfügbarkeit prüfen

Foliar Application of Magnesium Sulphate and Basal Application of Calcium Carbonate: A New Dimension in Production of Tasar Crops

International Journal of Industrial Entomology, 2012, 25(1), , pp.123-127

2012

Link zum Volltext

Verfügbarkeit prüfen

Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)

European heart journal, 2013-05, Vol.34 (20), p.1498-1505

2013

Link zum Volltext

Verfügbarkeit prüfen

Recurrent hypokalemic paralysis: An atypical presentation of hypothyroidism

Indian journal of endocrinology and metabolism, 2013-01, Vol.17 (1), p.174-176

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 300

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(260)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(127)
Humans
(83)
Animals
(59)
Biological And Medical Sciences
(48)
Physical Sciences
(44)
Medical Sciences
(40)
Pharmacology & Pharmacy
(37)
Chemistry
(31)
Factor Xa Inhibitors
(31)
Female
(31)
Pharmacology. Drug Treatments
(27)
Chemistry, Medicinal
(26)
Male
(25)
Blood. Blood Coagulation. Reticuloendothelial System
(24)
Biochemistry & Molecular Biology
(20)
Chemistry, Organic
(20)
Structure-Activity Relationship
(20)
Hematology
(19)
Rats
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy

The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancer

SYK inhibition and response prediction in diffuse large B-cell lymphoma

Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis

A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)

First‐in‐Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers

Critical role for Syk in responses to vascular injury

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-( N, N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles

Inhibitory effect of carboxylic acid group on hERG binding

The HTLV-I p30 Interferes with TLR4 Signaling and Modulates the Release of Pro- and Anti-inflammatory Cytokines from Human Macrophages

Synergistic Induction of Tissue Factor by Coagulation Factor Xa and TNF: Evidence for Involvement of Negative Regulatory Signaling Cascades

Human T-cell Lymphotrophic Virus Type I Rex and p30 Interactions Govern the Switch between Virus Latency and Replication

GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half‐life in a murine model of sickle cell disease

Benefits of leptin therapy in HIV patients

Genotoxicity of crotonaldehyde in the bone marrow and germ cells of laboratory mice

Human T-cell Leukemia Virus Type I p30 Nuclear/Nucleolar Retention Is Mediated through Interactions with RNA and a Constituent of the 60 S Ribosomal Subunit

MO040: Development of BBP-711, a small molecule inhibitor of glycolate oxidase for primary hyperoxaluria type 1 and recurrent kidney stone formers

Validation of a novel western blot assay to monitor patterns and levels of alpha dystroglycan in skeletal muscle of patients with limb girdle muscular dystrophies

Recombinant Antidote for Reversal of Anticoagulation by Factor Xa Inhibitors

Acromegaly without acral changes: A rare presentation

Foliar Application of Magnesium Sulphate and Basal Application of Calcium Carbonate: A New Dimension in Production of Tasar Crops

Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)

Recurrent hypokalemic paralysis: An atypical presentation of hypothyroidism

Suchergebnisse filtern